Suchergebnisse - "Ruggeri, Rosaria Maddalena"

PubPharm (132)

1

Challenges and pitfalls in the management of endocrine toxicities from immune checkpoint inhibitors : a case presentation of synchronous thyrotoxicosis and primary adrenal insufficiency in a melanoma patient

enthalten in: Hormones (Athens, Greece) | 2024

von Spagnolo, C. | Campo, I. | Campennì, A. | +5

2

Nodal metastasis in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)

enthalten in: Endocrine | 2024

von Campennì, A. | Torregrossa, L. | Ruggeri, R. | +3

3

Autoimmune Thyroid Disorders : The Mediterranean Diet as a Protective Choice

enthalten in: Nutrients | 2023

von Ruggeri, R. | Barbalace, M. | Croce, L. | +5

4

The Influence of Food Regimes on Oxidative Stress : A Permutation-Based Approach Using the NPC Test

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Zirilli, A. | Ruggeri, R. | Barbalace, M. | +5

5

Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration : A Real Life Study

enthalten in: Cancers | 2023

von Campennì, A. | Ruggeri, R. | Garo, M. | +9

6

Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients

enthalten in: Cancers | 2023

von Campennì, A. | Ruggeri, R. | Siracusa, M. | +10

7

Early diagnosis of parathyroid carcinoma : A challenging for physicians

enthalten in: Clinical endocrinology | 2023

von Campennì, A. | Ruggeri, R.

CommentOn: Clin Endocrinol (Oxf). 2022 Sep;97(3):250-257. - PMID 35120263

8

Clinical and molecular description of the first Italian cohort of 33 subjects with hypophosphatasia

enthalten in: Frontiers in endocrinology | 2023

von Cinque, L. | Pugliese, F. | Salcuni, A. | +27

9

Commentary : Fish and the thyroid: A Janus Bifrons relationship caused by pollutants and the omega-3 polyunsaturated fatty acids

enthalten in: Frontiers in endocrinology | 2023

von Hrelia, S. | Barbalace, M. | Cannavò, S. | +1

CommentOn: Front Endocrinol (Lausanne). 2022 May 27;13:891233. - PMID 35712237

10

Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors : From Clinical Studies to a Real-Life Scenario

enthalten in: Cancers | 2022

von Spagnolo, C. | Giuffrida, G. | Cannavò, S. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]